Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 270

    1.

    Antibody mediated B cell depletion prior to adoptive immunotherapy with T cells expressing CD20-specific chimeric T cell receptors facilitates eradication of leukemia in immunocompetent mice.

    James SE, Orgun NN, Tedder TF, Shlomchik MJ, Jensen MC, Lin Y, Greenberg PD, Press OW.

    Blood. 2009 Oct 30. [Epub ahead of print]PMID: 19880489 [PubMed - as supplied by publisher]Related articles

    2.

    CD19: a promising B cell target for rheumatoid arthritis.

    Tedder TF.

    Nat Rev Rheumatol. 2009 Oct;5(10):572-7.PMID: 19798033 [PubMed - in process]Related articles

    3.

    CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.

    Haas KM, Poe JC, Tedder TF.

    J Immunol. 2009 Sep 15;183(6):3661-71. Epub 2009 Aug 26.PMID: 19710450 [PubMed - indexed for MEDLINE]Related articles

    4.

    Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism.

    Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MA, Geuking MB, Beutler B, Tedder TF, Hardt WD, Bercik P, Verdu EF, McCoy KD, Macpherson AJ.

    Science. 2009 Jul 31;325(5940):617-20.PMID: 19644121 [PubMed - indexed for MEDLINE]Related articles

    5.

    CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling.

    Iwata Y, Yoshizaki A, Komura K, Shimizu K, Ogawa F, Hara T, Muroi E, Bae S, Takenaka M, Yukami T, Hasegawa M, Fujimoto M, Tomita Y, Tedder TF, Sato S.

    Am J Pathol. 2009 Aug;175(2):649-60. Epub 2009 Jul 2.PMID: 19574428 [PubMed - indexed for MEDLINE]Related articles

    6.

    Targeting B-cells mitigates autoimmune diabetes in NOD mice: what is plan B?

    Smith SH, Tedder TF.

    Diabetes. 2009 Jul;58(7):1479-81. No abstract available. PMID: 19564459 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.

    Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF.

    J Immunol. 2009 Jun 15;182(12):7459-72.PMID: 19494269 [PubMed - indexed for MEDLINE]Related articles

    8.

    Establishment of experimental eosinophilic vasculitis by IgE-mediated cutaneous reverse passive arthus reaction.

    Ishii T, Fujita T, Matsushita T, Yanaba K, Hasegawa M, Nakashima H, Ogawa F, Shimizu K, Takehara K, Tedder TF, Sato S, Fujimoto M.

    Am J Pathol. 2009 Jun;174(6):2225-33. Epub 2009 Apr 23.PMID: 19389931 [PubMed - indexed for MEDLINE]Related articles

    9.

    B cells contribute to ischemia/reperfusion-mediated tissue injury.

    Chen J, Crispín JC, Tedder TF, Dalle Lucca J, Tsokos GC.

    J Autoimmun. 2009 May-Jun;32(3-4):195-200. Epub 2009 Apr 1.PMID: 19342197 [PubMed - indexed for MEDLINE]Related articles

    10.

    B-lymphocyte depletion for the treatment of multiple sclerosis: now things really get interesting.

    Matsushita T, Tedder TF.

    Expert Rev Neurother. 2009 Mar;9(3):309-12. No abstract available. PMID: 19271937 [PubMed - indexed for MEDLINE]Related articles

    11.

    CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model.

    Komura K, Yanaba K, Horikawa M, Ogawa F, Fujimoto M, Tedder TF, Sato S.

    Arthritis Rheum. 2008 Nov;58(11):3574-84.PMID: 18975313 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    An L-selectin ligand distinct from P-selectin glycoprotein ligand-1 is expressed on endothelial cells and promotes neutrophil rolling in inflammation.

    Shigeta A, Matsumoto M, Tedder TF, Lowe JB, Miyasaka M, Hirata T.

    Blood. 2008 Dec 15;112(13):4915-23. Epub 2008 Sep 25.PMID: 18818390 [PubMed - indexed for MEDLINE]Related articles

    13.

    Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.

    Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF.

    J Clin Invest. 2008 Oct;118(10):3420-30.PMID: 18802481 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Regulatory B cells as inhibitors of immune responses and inflammation.

    Bouaziz JD, Yanaba K, Tedder TF.

    Immunol Rev. 2008 Aug;224:201-14. Review.PMID: 18759928 [PubMed - indexed for MEDLINE]Related articles

    15.

    B lymphocytes: how they develop and function.

    LeBien TW, Tedder TF.

    Blood. 2008 Sep 1;112(5):1570-80. Review.PMID: 18725575 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    B-lymphocyte contributions to human autoimmune disease.

    Yanaba K, Bouaziz JD, Matsushita T, Magro CM, St Clair EW, Tedder TF.

    Immunol Rev. 2008 Jun;223:284-99. Review.PMID: 18613843 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.

    Minard-Colin V, Xiu Y, Poe JC, Horikawa M, Magro CM, Hamaguchi Y, Haas KM, Tedder TF.

    Blood. 2008 Aug 15;112(4):1205-13. Epub 2008 May 21.PMID: 18495955 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

    Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF.

    Immunity. 2008 May;28(5):639-50.PMID: 18482568 [PubMed - indexed for MEDLINE]Related articles

    19.

    CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.

    Yoshizaki A, Iwata Y, Komura K, Ogawa F, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Tedder TF, Sato S.

    Am J Pathol. 2008 Jun;172(6):1650-63. Epub 2008 May 8.PMID: 18467694 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Isolation and generation of human dendritic cells.

    Tedder TF, Jansen PJ.

    Curr Protoc Immunol. 2001 May;Chapter 7:Unit 7.32.PMID: 18432844 [PubMed - indexed for MEDLINE]Related articles

    21.

    B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.

    Xiu Y, Wong CP, Bouaziz JD, Hamaguchi Y, Wang Y, Pop SM, Tisch RM, Tedder TF.

    J Immunol. 2008 Mar 1;180(5):2863-75.PMID: 18292508 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    CD22 regulates time course of both B cell division and antibody response.

    Onodera T, Poe JC, Tedder TF, Tsubata T.

    J Immunol. 2008 Jan 15;180(2):907-13.PMID: 18178830 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.

    DiLillo DJ, Hamaguchi Y, Ueda Y, Yang K, Uchida J, Haas KM, Kelsoe G, Tedder TF.

    J Immunol. 2008 Jan 1;180(1):361-71.PMID: 18097037 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice.

    Bouaziz JD, Yanaba K, Venturi GM, Wang Y, Tisch RM, Poe JC, Tedder TF.

    Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20878-83. Epub 2007 Dec 19.PMID: 18093919 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase.

    Aiba Y, Kameyama M, Yamazaki T, Tedder TF, Kurosaki T.

    Blood. 2008 Feb 1;111(3):1497-503. Epub 2007 Nov 19.PMID: 18025150 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Dendritic cell CD83: a therapeutic target or innocent bystander?

    Prazma CM, Tedder TF.

    Immunol Lett. 2008 Jan 15;115(1):1-8. Epub 2007 Oct 29. Review.PMID: 18001846 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis.

    Zabel MD, Heikenwalder M, Prinz M, Arrighi I, Schwarz P, Kranich J, von Teichman A, Haas KM, Zeller N, Tedder TF, Weis JH, Aguzzi A.

    J Immunol. 2007 Nov 1;179(9):6144-52.PMID: 17947689 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo.

    Prazma CM, Yazawa N, Fujimoto Y, Fujimoto M, Tedder TF.

    J Immunol. 2007 Oct 1;179(7):4550-62.PMID: 17878352 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.

    Kuwano Y, Prazma CM, Yazawa N, Watanabe R, Ishiura N, Kumanogoh A, Okochi H, Tamaki K, Fujimoto M, Tedder TF.

    Int Immunol. 2007 Aug;19(8):977-92.PMID: 17804692 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity.

    Yanaba K, Hamaguchi Y, Venturi GM, Steeber DA, St Clair EW, Tedder TF.

    J Immunol. 2007 Jul 15;179(2):1369-80.PMID: 17617630 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Endothelial selectins regulate skin wound healing in cooperation with L-selectin and ICAM-1.

    Yukami T, Hasegawa M, Matsushita Y, Fujita T, Matsushita T, Horikawa M, Komura K, Yanaba K, Hamaguchi Y, Nagaoka T, Ogawa F, Fujimoto M, Steeber DA, Tedder TF, Takehara K, Sato S.

    J Leukoc Biol. 2007 Sep;82(3):519-31. Epub 2007 Jun 26.PMID: 17595378 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Intercellular adhesion molecule-1 deficiency attenuates the development of skin fibrosis in tight-skin mice.

    Matsushita Y, Hasegawa M, Matsushita T, Fujimoto M, Horikawa M, Fujita T, Kawasuji A, Ogawa F, Steeber DA, Tedder TF, Takehara K, Sato S.

    J Immunol. 2007 Jul 1;179(1):698-707.PMID: 17579093 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    CD19 expression in B cells is important for suppression of contact hypersensitivity.

    Watanabe R, Fujimoto M, Ishiura N, Kuwano Y, Nakashima H, Yazawa N, Okochi H, Sato S, Tedder TF, Tamaki K.

    Am J Pathol. 2007 Aug;171(2):560-70. Epub 2007 Jun 7.PMID: 17556590 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice.

    Hayakawa I, Tedder TF, Zhuang Y.

    Immunology. 2007 Sep;122(1):73-9. Epub 2007 Apr 30.PMID: 17472721 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    CD25+CD4+ regulatory T cell migration requires L-selectin expression: L-selectin transcriptional regulation balances constitutive receptor turnover.

    Venturi GM, Conway RM, Steeber DA, Tedder TF.

    J Immunol. 2007 Jan 1;178(1):291-300.PMID: 17182566 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.

    Tedder TF, Baras A, Xiu Y.

    Springer Semin Immunopathol. 2006 Dec;28(4):351-64. Epub 2006 Nov 8.PMID: 17091246 [PubMed - in process]Related articles

    37.

    Decreased expression levels of CD22 and L-selectin on peripheral blood B lymphocytes from patients with bullous pemphigoid.

    Inaoki M, Echigo T, Hayashi H, Nagaoka T, Hasegawa M, Takehara K, Fujimoto W, Tedder TF, Sato S.

    J Autoimmun. 2006 Nov;27(3):196-202. Epub 2006 Oct 18.PMID: 17055225 [PubMed - indexed for MEDLINE]Related articles

    38.

    B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.

    Hasegawa M, Hamaguchi Y, Yanaba K, Bouaziz JD, Uchida J, Fujimoto M, Matsushita T, Matsushita Y, Horikawa M, Komura K, Takehara K, Sato S, Tedder TF.

    Am J Pathol. 2006 Sep;169(3):954-66.PMID: 16936269 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo.

    Haas KM, Sen S, Sanford IG, Miller AS, Poe JC, Tedder TF.

    J Immunol. 2006 Sep 1;177(5):3063-73.PMID: 16920943 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    CD83: a regulatory molecule of the immune system with great potential for therapeutic application.

    Fujimoto Y, Tedder TF.

    J Med Dent Sci. 2006 Jun;53(2):85-91. Review.PMID: 16913569 [PubMed - indexed for MEDLINE]Related articles

    41.

    Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.

    Hamaguchi Y, Xiu Y, Komura K, Nimmerjahn F, Tedder TF.

    J Exp Med. 2006 Mar 20;203(3):743-53. Epub 2006 Mar 6.PMID: 16520392 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.

    Matsushita T, Fujimoto M, Hasegawa M, Komura K, Takehara K, Tedder TF, Sato S.

    Am J Pathol. 2006 Mar;168(3):812-21.PMID: 16507897 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    L-selectin and intercellular adhesion molecule-1 regulate the development of Concanavalin A-induced liver injury.

    Kawasuji A, Hasegawa M, Horikawa M, Fujita T, Matsushita Y, Matsushita T, Fujimoto M, Steeber DA, Tedder TF, Takehara K, Sato S.

    J Leukoc Biol. 2006 Apr;79(4):696-705. Epub 2006 Feb 3.PMID: 16461740 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells.

    Pieper M, Scheffold C, Duwe S, Rossig C, Bisping G, Stelljes M, Tedder TF, Jurgens H, Berdel WE, Kienast J.

    Leukemia. 2006 Apr;20(4):729-32. No abstract available. PMID: 16437143 [PubMed - indexed for MEDLINE]Related articles

    45.

    Regulation of local and metastatic host-mediated anti-tumour mechanisms by L-selectin and intercellular adhesion molecule-1.

    Yamada M, Yanaba K, Hasegawa M, Matsushita Y, Horikawa M, Komura K, Matsushita T, Kawasuji A, Fujita T, Takehara K, Steeber DA, Tedder TF, Sato S.

    Clin Exp Immunol. 2006 Feb;143(2):216-27.PMID: 16412045 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    B cell antigen receptor and CD40 differentially regulate CD22 tyrosine phosphorylation.

    Fujimoto M, Kuwano Y, Watanabe R, Asashima N, Nakashima H, Yoshitake S, Okochi H, Tamaki K, Poe JC, Tedder TF, Sato S.

    J Immunol. 2006 Jan 15;176(2):873-9.PMID: 16393971 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    New prospects for autoimmune disease therapy: B cells on deathwatch.

    St Clair EW, Tedder TF.

    Arthritis Rheum. 2006 Jan;54(1):1-9. Review. No abstract available. PMID: 16385491 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.

    Lee Y, Haas KM, Gor DO, Ding X, Karp DR, Greenspan NS, Poe JC, Tedder TF.

    J Immunol. 2005 Dec 15;175(12):8011-23.PMID: 16339538 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.

    Tedder TF, Poe JC, Haas KM.

    Adv Immunol. 2005;88:1-50. Review.PMID: 16227086 [PubMed - in process]Related articles

    50.

    Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease.

    Yazawa N, Hamaguchi Y, Poe JC, Tedder TF.

    Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15178-83. Epub 2005 Oct 10.PMID: 16217038 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...